X4 Pharmaceuticals (XFOR) Tops Q4 EPS by 5c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Oracle’s Ellison cancels plan to sell up to 50 mln shares
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says